Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Contrast media

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44347   clinical trials with a EudraCT protocol, of which   7375   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    61 result(s) found for: Contrast media. Displaying page 1 of 4.
    1  2  3  4  Next»
    EudraCT Number: 2004-005172-17 Sponsor Protocol Number: CHARITE-WKD-2005-1 Start Date*: 2005-09-09
    Sponsor Name:Charité/Campus Virchow-Klinikum, Medizinische Klinik m. S. Kardiologie
    Full Title: Renal haemodynamics during application of contrast media in patients undergoing cardiac catheterisation with high risk of acute renal failure: randomized comparison of different contrast media
    Medical condition: Patients with allready existing chronic renal failure undergoing a cardiac catheterisation for clinical reasons may develope an acute renal failure due to radio contrast media. This trial compares...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2014-000681-22 Sponsor Protocol Number: VIS-13-08 Start Date*: 2015-02-25
    Sponsor Name:ErasmusMC
    Full Title: EFFECT OF ISO-OSMOLAR CONTRAST MEDIUM ON CORONARY OPACIFICATION AND HEART RHYTHM IN CORONARY CT ANGIOGRAPHY (ISO-COR)
    Medical condition: Patients with suspected coronary artery disease and clinically referred for coronary CTA.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-013547-11 Sponsor Protocol Number: 09-059 Start Date*: 2009-07-16
    Sponsor Name:Leids Universitair Medisch Centrum
    Full Title: Sodium Bicarbonate for the prevention of Contrast Induced Nephropathy in patients undergoing CTPA
    Medical condition: The prevention of Contrast Induced Nephropathy is under investigation. Contrast induced nephropathy (CIN) can occur after injecting radiographic iso osmolair contrast media. Patients with a renal i...
    Disease: Version SOC Term Classification Code Term Level
    12.0 10037790 Radiocontrast nephropathy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-003614-87 Sponsor Protocol Number: ET31068 Start Date*: 2015-03-27
    Sponsor Name:Oslo University Hospital
    Full Title: Novel Imaging of the Eustachian Tube, a CT study using dilute iodixanol in an adult population
    Medical condition: Otitis media With effusion
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NO (Completed)
    Trial results: View results
    EudraCT Number: 2013-002437-37 Sponsor Protocol Number: 13-1-033 Start Date*: 2014-07-31
    Sponsor Name:Maastricht University Medical Centre
    Full Title: Effects on Intra-Coronary Attenuation using low iodine concentrations (240 mg, 300 mg and 370 mg iodine per ml) while maintaining identical IDR
    Medical condition: atypical or typical complaints of angina pectoris with no previous cardiovascular medical history low to intermediate risk for atherosclerosis referred for coronary CTA to rule out CAD
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2017-000940-17 Sponsor Protocol Number: 64Cu Start Date*: 2018-05-07
    Sponsor Name:
    Full Title: Phase IIa clinical study of 64 CuCl2: efficacy and safety of a new tracer for urologic tumors
    Medical condition: Genitourinary tract tumors in male patients
    Disease:
    Population Age: Elderly Gender: Male
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-004207-11 Sponsor Protocol Number: Gd-NEPHRIC-01 Start Date*: 2006-01-03
    Sponsor Name:Malmö University Hospital, Dep of Radiology
    Full Title: Single blind study comparing nephrotoxicity in patients with decreased renal function after intravenous gadodiamide(Omniscan) or gadopenteate (Magnevist) injection in routine clinical Magnetic Reso...
    Medical condition: Patients with diabetes (type I or II) and impaired renal function defined as pre-study serum creatinine ≥150µmol/l if man and 133µmol/l if woman or an estimated prestudy glomerular filtration rate ...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-011175-70 Sponsor Protocol Number: 805 Start Date*: 2009-05-28
    Sponsor Name:Liverpool Heart and Chest Hospital
    Full Title: A randomised factorial trial of N-acetylcysteine prophylaxis and iso-osmolar versus low-osmolar contrast media on kidney function in patients at risk of contrast induced nephropathy following cardi...
    Medical condition: Contrast-induced nephropathy following cardiac catheterisation
    Disease: Version SOC Term Classification Code Term Level
    12.1 10010836 Contrast media reaction LLT
    12.1 10066973 Contrast media allergy LLT
    12.1 10029151 Nephropathy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2021-000827-11 Sponsor Protocol Number: T50/2021 Start Date*: 2022-09-02
    Sponsor Name:Turku University Hospital
    Full Title: Clinical use of USPIO contrast media in the assessment of pelvic lymph node metastasis in rectal cancer.
    Medical condition: Pelvic lymph node metastasis in rectal cancer.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2005-004170-25 Sponsor Protocol Number: MH-110 Start Date*: Information not available in EudraCT
    Sponsor Name:Bracco Imaging S.p.A.
    Full Title: A PHASE III, MULTI-CENTER, OPEN-LABEL STUDY TO EVALUATE SAFETY AND EFFICACY OF MULTIHANCE® AT THE DOSE OF 0.10 mmol/kg IN MAGNETIC RESONANCE IMAGING OF THE CENTRAL NERVOUS SYSTEM IN PEDIATRIC PA...
    Medical condition: imaging diagnosis of highly suspected or known brain and/or spine disease, which are known to impair the Blood Brain Barrier Function
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed) BE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2012-004742-16 Sponsor Protocol Number: FARM823BHC Start Date*: 2013-01-04
    Sponsor Name:AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI
    Full Title: Evaluation of the risk of nephrotoxicity caused by the intravenous administration of nonionic iodinated contrast media
    Medical condition: The present study was designed to determine the incidence of serious complications with special reference to contrast induced nephropaty (CIN) in patients receiving iv iodinated contrast media (I...
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-001796-11 Sponsor Protocol Number: contrast 01/2007 Start Date*: 2008-01-30
    Sponsor Name:Institute for Diagnostic Radiology and Neuroradiology, Ernst-Moritz-Arndt University Greifswald
    Full Title:
    Medical condition: The following trial should be performed in patients with a stenosis of supraaortal and intracranial vessels, who are subjected to a plain cranial CT and CT angiography, which is considered to be a ...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10065141 Vascular diagnostic procedure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2011-001472-18 Sponsor Protocol Number: UDT-2/PHT Start Date*: 2011-05-10
    Sponsor Name:STZ 1172 Gesundheitsförderung und Stoffwechselforschung
    Full Title: Double-Blind, Randomised, Cross-Over, Placebo-Controlled, Single-Centre Phase IIa Clinical Study on the Influence of Udenafil on the Portal Flow in Cirrhotic Patients with Portal Hypertension
    Medical condition: Portal hypertension, liver cirrhosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-000050-32 Sponsor Protocol Number: GE012-097 Start Date*: Information not available in EudraCT
    Sponsor Name:GE Healthcare Ltd. and its affiliates
    Full Title: A phase 4 randomized, double-blind study comparing patient comfort and safety between iodixanol 320 mg I/ml and iopamidol 370 mg I/ml in patients undergoing contrast-enhanced computed tomographic (...
    Medical condition: Patients undergoing CECT imaging of the abdomen/pelvis as part of their routine medical care.
    Disease: Version SOC Term Classification Code Term Level
    13.1 10018065 - General disorders and administration site conditions 10022086 Injection site pain PT
    13.1 10018065 - General disorders and administration site conditions 10013082 Discomfort PT
    13.1 10018065 - General disorders and administration site conditions 10003051 Application site pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2014-001838-29 Sponsor Protocol Number: TEATE Start Date*: 2015-01-08
    Sponsor Name:"G. d'Annunzio" University
    Full Title: PrevenTion of contrast‐inducEd nephroAThy with urinE alkalinization: the TEATE study
    Medical condition: contrast‐induced nephroathy
    Disease: Version SOC Term Classification Code Term Level
    17.0 10022117 - Injury, poisoning and procedural complications 10010836 Contrast media reaction PT
    17.0 10038359 - Renal and urinary disorders 10029155 Nephropathy toxic PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-004192-12 Sponsor Protocol Number: NL66079.029.18 Start Date*: 2019-08-05
    Sponsor Name:Amsterdam UMC, location VU medical Center
    Full Title: Oil- based versus water-based contrast media for hysterosalpingography (HSG) in infertile women with unevaluated indications: a randomized controlled trial
    Medical condition: The research population consists of infertile couples who have tried to conceive for at least 12 months, or have oligo- or anovulation. We will focus on women with ovulation disorders, or at high r...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2008-000583-16 Sponsor Protocol Number: 312041 Start Date*: 2009-03-13
    Sponsor Name:Bayer Schering Pharma AG (BSP)
    Full Title: Multi-center, randomized comparison study to eVALUatE outcomes and resource needs of imaging and treatment following Primovist-enhanced MRI of the liver in comparison to extracellular contrast medi...
    Medical condition: Patients with history of colorectal cancer and known or suspected metachronous liver metastasis(es) scheduled to undergo contrast-enhanced tomographic imaging (i.e. CE-MRI or CE-CT) of the liver
    Disease: Version SOC Term Classification Code Term Level
    9.1 10052358 Colorectal cancer metastatic LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed) SE (Completed) NL (Completed) ES (Completed) IT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2011-005597-28 Sponsor Protocol Number: DIADEMA Start Date*: 2012-04-10
    Sponsor Name:CASA DI CURA ABANO TERME POLISPECIALISTICA E TERMALE
    Full Title: Evaluation of the Discomfort Contrast Induced during Angiographic evaluation of peripheral arterial occlusive disease to define the treatment approach for percutaneous transluminal balloon angiopla...
    Medical condition: Critical limb ischemia in diabetic patients with wounds in the foot.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10047065 - Vascular disorders 10012684 Diabetic peripheral vascular disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-021826-37 Sponsor Protocol Number: ISO-44-012 Start Date*: 2010-10-19
    Sponsor Name:GUERBET
    Full Title: Xenetix 350 : comparative assessment of image quality for coronary CT angiography
    Medical condition: Symptomatic patients suspected for coronary artery disease scheduled for a coronary CT angiography.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10060808 Computerized tomogram coronary artery LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2007-005364-27 Sponsor Protocol Number: 12/2007/U/Sper Start Date*: 2007-09-25
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: Ultrasonographic characterization of small nodules in cirrhotic patients using contrast media through splancnic infusion
    Medical condition: hepatic cirrhosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019641 Hepatic cirrhosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Jul 05 14:45:11 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA